International Immunology, Vol. 12, No. 10, 1467-1477,
October 2000
© 2000 Japanese Society for Immunology
Neonatal induction of tolerance to Th2-mediated autoimmunity in rats
INSERM U430 Hôpital Broussais, Pavillon Leriche, 96 rue Didot, 75674 Paris Cedex 14, France
1 INSERM U28 Hôpital Purpan, Pavillon Lefebvre, Place du Dr Baylac, 31059 Toulouse Cedex, France
Correspondence to: B. Bellon
Brown-Norway (BN) rats are highly susceptible to drug-induced immune dysregulations and when injected with mercuric chloride (HgCl2) or sodium aurothiopropanolsulfonate (ATPS), they develop a syndrome characterized by a polyclonal B cell activation depending upon CD4+ Th2 cells that recognize self-MHC class II molecules. Since peripheral tolerance of Th2 cells might be crucial in the prevention of immunological manifestations such as allergy, establishing conditions for inducing tolerance to HgCl2- or ATPS-mediated immune manifestations appeared to be of large interest. We report here that BN rats neonatally injected with HgCl2: (i) do not develop the mercury disease, (ii) remain resistant to HgCl2-induced autoimmunity at 8 weeks of age and later, provided they are regularly exposed to HgCl2, (iii) are still susceptible to ATPS-induced immune manifestations, and (iv) exhibit spleen cells that adoptively transfer tolerance to HgCl2-induced autoimmunity in naive, slightly irradiated, syngeneic recipients. These findings demonstrate that dominant specific tolerance can be neonatally induced using a chemical otherwise responsible for Th2-mediated autoimmunity.
Keywords: heavy metal salts, neonatal tolerance, rodents, Th2 cells
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A.-C. Field, L. Caccavelli, M.-F. Bloch, and B. Bellon Regulatory CD8+ T Cells Control Neonatal Tolerance to a Th2-Mediated Autoimmunity J. Immunol., March 1, 2003; 170(5): 2508 - 2515. [Abstract] [Full Text] [PDF] |
||||
